BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) posted its quarterly earnings data on Friday. The company reported ($0.01) EPS for the quarter, Zacks reports.
BioNxt Solutions Stock Performance
BNXTF opened at $0.28 on Friday. BioNxt Solutions has a 12 month low of $0.14 and a 12 month high of $0.79. The stock has a 50-day moving average of $0.23 and a 200 day moving average of $0.32. The firm has a market cap of $37.60 million, a P/E ratio of -5.53 and a beta of 0.70.
About BioNxt Solutions
BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.
BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.
Further Reading
- Five stocks we like better than BioNxt Solutions
- MarketBeat Week in Review – 08/24 – 08/28
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
-tbk-logo-1200x675.png){kind=logo}
